Indications
Twinrix Paediatric is indicated for use in non-immune infants, children and adolescents from one year up to and including 15 years who are at risk of both hepatitis-A and hepatitis-B infection.
Composition
- Active substance
- hepatitis A virus (inactivated), hepatitis B surface antigen
- International name (INN)
- hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Twinrix Paediatric
- Active substance
- hepatitis A virus (inactivated), hepatitis B surface antigen
- ATC code
- J07BC20
- Therapeutic area